Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:edaravone
go back to main search page
Accession:CHEBI:31530 term browser browse the term
Definition:A pyrazolone that is 2,4-dihydro-3H-pyrazol-3-one which is substituted at positions 2 and 5 by phenyl and methyl groups, respectively.
Synonyms:related_synonym: 1-phenyl-3-methyl-5-oxo-2-pyrazoline;   2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one;   3-methyl-1-phenyl-2-pyrazolin-5-one;   3-methyl-1-phenyl-5-pyrazolone;   3-methyl-1-phenylpyrazol-5-one;   C.I. developer 1;   Formula=C10H10N2O;   InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3;   InChIKey=QELUYTUMUWHWMC-UHFFFAOYSA-N;   Radicut;   SMILES=CC1=NN(C(=O)C1)c1ccccc1;   developer Z;   methylphenylpyrazolone;   norphenazone;   phenyl methyl pyrazolone;   phenylmethylpyrazolone
 xref: Beilstein:609575;   CAS:89-25-8;   Drug_Central:4156;   Gmelin:241147;   HMDB:HMDB0006240;   KEGG:C13008;   KEGG:D01552;   LINCS:LSM-5486
 xref_mesh: MESH:C005435
 xref: PMID:12935312;   PMID:14758002;   PMID:15304976;   PMID:16545576;   PMID:17280782;   PMID:17997244;   PMID:18485133;   PMID:25348283;   PMID:26196041;   PMID:26778341;   PMID:27018216;   PMID:27037019;   PMID:27056755;   PMID:27116382;   PMID:27128210



show annotations for term's descendants           Sort by:
 
edaravone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adora1 adenosine A1 receptor multiple interactions ISO Edaravone inhibits the reaction [Corticosterone results in decreased expression of ADORA1 mRNA] CTD PMID:31344373 NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions EXP Edaravone inhibits the reaction [Lipopolysaccharides results in decreased expression of AGTR1A mRNA] CTD PMID:19118600 NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
JBrowse link
G Agtr2 angiotensin II receptor, type 2 multiple interactions EXP Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR2 mRNA] CTD PMID:19118600 NCBI chr  X:112,119,673...112,124,060
Ensembl chr  X:112,120,228...112,124,057
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions EXP Edaravone inhibits the reaction [[IL1B protein results in increased phosphorylation of AKT1 protein] which results in increased expression of IL1R1 mRNA]; Edaravone inhibits the reaction [[IL1B protein results in increased phosphorylation of AKT1 protein] which results in increased expression of IL1R1 protein] CTD PMID:18078833 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions EXP Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; Edaravone inhibits the reaction [Hydrogen Peroxide affects the localization of ALOX5 protein] CTD PMID:18951527 NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
JBrowse link
G App amyloid beta precursor protein multiple interactions EXP Edaravone inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA]; Edaravone inhibits the reaction [APP protein modified form results in increased expression of BAX mRNA]; Edaravone inhibits the reaction [APP protein modified form results in increased expression of CYCS mRNA] CTD PMID:26111763 NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP Edaravone inhibits the reaction [APP protein modified form results in increased expression of BAX mRNA] CTD PMID:26111763 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions EXP Edaravone inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA] CTD PMID:26111763 NCBI chr13:22,689,783...22,853,920 JBrowse link
G Casp12 caspase 12 multiple interactions EXP Edaravone inhibits the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of CASP12 protein] CTD PMID:21429313 NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
JBrowse link
G Casp3 caspase 3 multiple interactions
increases activity
EXP
ISO
Edaravone inhibits the reaction [Paraquat results in increased cleavage of CASP3 protein]; Edaravone inhibits the reaction [PRNP protein alternative form results in increased activity of CASP3 protein]
Edaravone analog results in increased activity of CASP3 protein
CTD PMID:20806394 PMID:25684395 PMID:25947082 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp7 caspase 7 increases activity ISO Edaravone analog results in increased activity of CASP7 protein CTD PMID:25684395 NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
JBrowse link
G Casp8 caspase 8 decreases expression EXP Edaravone results in decreased expression of CASP8 protein CTD PMID:17967739 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
JBrowse link
G Casp9 caspase 9 increases activity ISO Edaravone analog results in increased activity of CASP9 protein CTD PMID:25684395 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G Cat catalase multiple interactions ISO Edaravone inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein] CTD PMID:32135237 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G Ccl12 chemokine (C-C motif) ligand 12 multiple interactions EXP Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL12 mRNA] CTD PMID:12954792 NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
decreases expression
EXP Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein]; Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CCL2 protein]
Edaravone results in decreased expression of CCL2 mRNA; Edaravone results in decreased expression of CCL2 protein
CTD PMID:12954792 PMID:15948865 PMID:18803305 PMID:19381132 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 decreases expression EXP Edaravone results in decreased expression of CCL3 mRNA CTD PMID:15948865 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
JBrowse link
G Comt catechol-O-methyltransferase multiple interactions ISO Edaravone inhibits the reaction [Corticosterone results in decreased expression of COMT mRNA] CTD PMID:31344373 NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression
multiple interactions
EXP Edaravone results in decreased expression of CXCL1 mRNA; Edaravone results in decreased expression of CXCL1 protein
Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 protein]
CTD PMID:14654979 PMID:15629513 NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions EXP Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CXCL12 protein]; Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CXCL12 protein] CTD PMID:18803305 NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 decreases expression
multiple interactions
EXP Edaravone results in decreased expression of CXCL2 mRNA
Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL2 mRNA]
CTD PMID:12954792 PMID:15948865 NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression EXP Edaravone results in decreased expression of CXCL3 mRNA CTD PMID:15948865 NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions EXP Edaravone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA] CTD PMID:18643790 NCBI chr  X:13,360,583...13,392,517
Ensembl chr  X:13,359,430...13,392,586
JBrowse link
G Cycs cytochrome c, somatic multiple interactions EXP Edaravone inhibits the reaction [APP protein modified form results in increased expression of CYCS mRNA] CTD PMID:26111763 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
JBrowse link
G Daxx death-domain associated protein decreases expression EXP Edaravone results in decreased expression of DAXX mRNA; Edaravone results in decreased expression of DAXX protein CTD PMID:17967739 NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
JBrowse link
G Ephx2 epoxide hydrolase 2 multiple interactions ISO Edaravone inhibits the reaction [Cisplatin results in decreased expression of EPHX2 protein] CTD PMID:26165641 NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases expression EXP Edaravone results in increased expression of ERN1 mRNA CTD PMID:19558813 NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
JBrowse link
G Fadd Fas associated via death domain decreases expression EXP Edaravone results in decreased expression of FADD mRNA; Edaravone results in decreased expression of FADD protein CTD PMID:17967739 NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions ISO Edaravone inhibits the reaction [Corticosterone results in decreased expression of FKBP5 mRNA] CTD PMID:31344373 NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions ISO Edaravone inhibits the reaction [cobaltous chloride results in increased expression of FLT1 mRNA]; Edaravone inhibits the reaction [cobaltous chloride results in increased expression of FLT1 protein] CTD PMID:24840734 NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions ISO [Edaravone inhibits the reaction [HIF1A protein binds to VEGFA promoter]] which affects the expression of VEGFA mRNA; Edaravone inhibits the reaction [HIF1A protein binds to VEGFA promoter]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] CTD PMID:17889387 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions
ISO
EXP
Edaravone results in increased expression of HMOX1 mRNA; Edaravone results in increased expression of HMOX1 protein
Edaravone promotes the reaction [Carbon Monoxide results in increased expression of HMOX1 protein]
CTD PMID:25348283 PMID:25422538 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression EXP Edaravone results in decreased expression of HSPA1A mRNA; Edaravone results in decreased expression of HSPA1A protein CTD PMID:19338546 PMID:19694712
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions EXP Edaravone promotes the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 protein] CTD PMID:21429313 NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases expression EXP Edaravone results in decreased expression of ICAM1 mRNA; Edaravone results in decreased expression of ICAM1 protein alternative form CTD PMID:15948865 PMID:16301206 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
JBrowse link
G Ifng interferon gamma multiple interactions EXP Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IFNG mRNA]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein] CTD PMID:12954792 PMID:15629513 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
JBrowse link
G Il10 interleukin 10 multiple interactions EXP Edaravone inhibits the reaction [Carbon Tetrachloride results in increased expression of IL10 mRNA]; Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL10 mRNA] CTD PMID:12954792 PMID:14567445 NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases expression
decreases activity
ISO
EXP
Edaravone inhibits the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of IL1B mRNA]; Edaravone inhibits the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of IL1B protein]
Edaravone results in decreased expression of IL1B mRNA
Edaravone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Edaravone inhibits the reaction [[IL1B protein results in increased phosphorylation of AKT1 protein] which results in increased expression of IL1R1 mRNA]; Edaravone inhibits the reaction [[IL1B protein results in increased phosphorylation of AKT1 protein] which results in increased expression of IL1R1 protein]; Edaravone inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Edaravone inhibits the reaction [IL1B protein results in increased localization of and results in increased activity of RELA protein]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of IL1B protein]; Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of IL1B protein]
Edaravone results in decreased activity of IL1B protein
CTD PMID:15629513 PMID:15948865 PMID:16390820 PMID:18078833 PMID:18803305 More... NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il1r1 interleukin 1 receptor type 1 multiple interactions EXP Edaravone inhibits the reaction [[IL1B protein results in increased phosphorylation of AKT1 protein] which results in increased expression of IL1R1 mRNA]; Edaravone inhibits the reaction [[IL1B protein results in increased phosphorylation of AKT1 protein] which results in increased expression of IL1R1 protein] CTD PMID:18078833 NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
JBrowse link
G Il4 interleukin 4 multiple interactions EXP Edaravone inhibits the reaction [Carbon Tetrachloride results in increased expression of IL4 mRNA] CTD PMID:14567445 NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
JBrowse link
G Il6 interleukin 6 affects activity
decreases expression
multiple interactions
EXP Edaravone affects the activity of IL6 protein
Edaravone results in decreased expression of IL6 mRNA
Edaravone inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 mRNA]; Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]; Edaravone inhibits the reaction [Paraquat results in increased expression of IL6 protein]; Edaravone promotes the reaction [Taurocholic Acid results in increased expression of IL6 mRNA]
CTD PMID:12954792 PMID:14567445 PMID:15629865 PMID:18031376 PMID:20035747 More... NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 decreases activity ISO Edaravone results in decreased activity of MAP3K5 protein CTD PMID:15824197 NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation
decreases phosphorylation
ISO Edaravone results in increased phosphorylation of MAPK8 protein
Edaravone results in decreased phosphorylation of MAPK8 protein
CTD PMID:15824197 PMID:19954754 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
JBrowse link
G Mmp2 matrix metallopeptidase 2 decreases expression
multiple interactions
EXP Edaravone results in decreased expression of MMP2 protein
Edaravone inhibits the reaction [Paraquat results in increased expression of MMP2 mRNA]
CTD PMID:19381132 PMID:21040696 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP Edaravone inhibits the reaction [PLAT protein results in increased expression of and results in increased activity of MMP9 protein]; Edaravone inhibits the reaction [PLAT protein results in increased expression of MMP9 mRNA] CTD PMID:19095969 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
JBrowse link
G Mpo myeloperoxidase affects expression
decreases activity
multiple interactions
decreases expression
EXP Edaravone affects the expression of MPO mRNA
Edaravone results in decreased activity of MPO protein
Edaravone inhibits the reaction [Taurocholic Acid results in increased activity of MPO protein]
Edaravone results in decreased expression of MPO protein
CTD PMID:14654979 PMID:18031376 PMID:19694712 PMID:20035747 NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions EXP Edaravone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NCF1 mRNA] CTD PMID:18643790 NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
JBrowse link
G Ndufs1 NADH:ubiquinone oxidoreductase core subunit S1 multiple interactions EXP Edaravone inhibits the reaction [Rotenone results in decreased expression of NDUFS1 mRNA] CTD PMID:27108097 NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
JBrowse link
G Ndufs4 NADH:ubiquinone oxidoreductase subunit S4 multiple interactions EXP Edaravone inhibits the reaction [Rotenone results in decreased expression of NDUFS4 mRNA] CTD PMID:27108097 NCBI chr 2:45,951,327...46,061,829
Ensembl chr 2:45,951,313...46,061,846
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 affects localization
multiple interactions
ISO
EXP
Edaravone affects the localization of NFE2L2 protein
[Edaravone co-treated with Chlorpyrifos] results in increased expression of NFE2L2 protein; Edaravone promotes the reaction [Carbon Monoxide results in increased expression of NFE2L2 protein]
CTD PMID:25348283 PMID:25422538 PMID:30758894 NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
JBrowse link
G Nfkbia NFKB inhibitor alpha increases expression EXP Edaravone results in increased expression of NFKBIA mRNA CTD PMID:18078833 NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
JBrowse link
G Ngf nerve growth factor increases expression
multiple interactions
ISO Edaravone results in increased expression of NGF mRNA; Edaravone results in increased expression of NGF protein
pyrazolanthrone inhibits the reaction [Edaravone results in increased expression of NGF mRNA]; pyrazolanthrone inhibits the reaction [Edaravone results in increased expression of NGF protein]; U 0126 inhibits the reaction [Edaravone results in increased expression of NGF mRNA]; U 0126 inhibits the reaction [Edaravone results in increased expression of NGF protein]
CTD PMID:19954754 NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
JBrowse link
G Nos1 nitric oxide synthase 1 multiple interactions EXP Edaravone inhibits the reaction [Pilocarpine results in increased expression of NOS1 protein] CTD PMID:18672383 NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases degradation
decreases expression
ISO
EXP
Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]
Edaravone results in increased degradation of NOS2 mRNA
Edaravone results in decreased expression of NOS2 protein
Edaravone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Edaravone inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Edaravone inhibits the reaction [Pilocarpine results in increased expression of NOS2 protein]
CTD PMID:15629513 PMID:18078833 PMID:18496239 PMID:18672383 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Nos3 nitric oxide synthase 3 increases expression
decreases degradation
EXP
ISO
Edaravone results in increased expression of NOS3 mRNA; Edaravone results in increased expression of NOS3 protein
Edaravone results in decreased degradation of NOS3 mRNA
CTD PMID:12969758 PMID:15721014 NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
JBrowse link
G Nppa natriuretic peptide A decreases expression ISO Edaravone results in decreased expression of NPPA mRNA CTD PMID:15824197 NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO Edaravone analog results in increased cleavage of PARP1 protein CTD PMID:25684395 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
JBrowse link
G Plat plasminogen activator, tissue type multiple interactions EXP Edaravone inhibits the reaction [PLAT protein results in increased activity of RELA protein]; Edaravone inhibits the reaction [PLAT protein results in increased expression of and results in increased activity of MMP9 protein]; Edaravone inhibits the reaction [PLAT protein results in increased expression of MMP9 mRNA] CTD PMID:19095969 NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions EXP Edaravone inhibits the reaction [Rotenone results in decreased expression of PPARGC1A mRNA] CTD PMID:30240821 NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
JBrowse link
G Prnp prion protein multiple interactions EXP Edaravone inhibits the reaction [PRNP protein alternative form results in decreased activity of SOD1 protein]; Edaravone inhibits the reaction [PRNP protein alternative form results in decreased activity of SOD2 protein]; Edaravone inhibits the reaction [PRNP protein alternative form results in increased activity of CASP3 protein] CTD PMID:20806394 NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
decreases expression
EXP Edaravone inhibits the reaction [IL1B protein results in increased localization of and results in increased activity of RELA protein]; Edaravone inhibits the reaction [PLAT protein results in increased activity of RELA protein]
Edaravone results in decreased expression of RELA protein
CTD PMID:18078833 PMID:19095969 PMID:19381132 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
JBrowse link
G Sdc2 syndecan 2 multiple interactions EXP Edaravone inhibits the reaction [SDC2 protein promotes the reaction [Oxygen deficiency results in increased abundance of Reactive Oxygen Species]]; Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CCL2 protein]; Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CXCL12 protein]; Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of IL1B protein]; Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of TNF protein] CTD PMID:18803305 NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
JBrowse link
G Sele selectin E decreases expression EXP Edaravone results in decreased expression of SELE mRNA; Edaravone results in decreased expression of SELE protein CTD PMID:17064733 NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
JBrowse link
G Slc6a15 solute carrier family 6 member 15 multiple interactions ISO Edaravone inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA] CTD PMID:31344373 NCBI chr 7:38,553,055...38,607,239
Ensembl chr 7:38,553,196...38,607,239
JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions EXP Edaravone inhibits the reaction [PRNP protein alternative form results in decreased activity of SOD1 protein] CTD PMID:20806394 NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions EXP Edaravone inhibits the reaction [PRNP protein alternative form results in decreased activity of SOD2 protein] CTD PMID:20806394 NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP Edaravone inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA] CTD PMID:21040696 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
JBrowse link
G Th tyrosine hydroxylase multiple interactions EXP Edaravone inhibits the reaction [Rotenone results in decreased expression of TH protein] CTD PMID:27108097 NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions EXP Edaravone inhibits the reaction [Paraquat results in increased expression of TIMP1 mRNA] CTD PMID:21040696 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:1,212,972...1,217,664
JBrowse link
G Tnf tumor necrosis factor multiple interactions
decreases expression
EXP Edaravone inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA]; Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; Edaravone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of TNF protein]; Edaravone inhibits the reaction [Paraquat results in increased expression of TNF protein]; Edaravone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of TNF protein]; Edaravone promotes the reaction [Taurocholic Acid results in increased expression of TNF mRNA]
Edaravone results in decreased expression of TNF mRNA; Edaravone results in decreased expression of TNF protein
CTD PMID:12954792 PMID:14567445 PMID:15629513 PMID:15948865 PMID:17064733 More... NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
JBrowse link
G Ucp2 uncoupling protein 2 multiple interactions EXP Edaravone inhibits the reaction [Isoproterenol results in increased expression of UCP2 mRNA]; Edaravone inhibits the reaction [Isoproterenol results in increased expression of UCP2 protein] CTD PMID:16580698 NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 decreases expression EXP Edaravone results in decreased expression of VCAM1 protein CTD PMID:19381132 NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO [Edaravone inhibits the reaction [HIF1A protein binds to VEGFA promoter]] which affects the expression of VEGFA mRNA; Edaravone inhibits the reaction [HIF1A protein binds to VEGFA promoter]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA protein] CTD PMID:17889387 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
JBrowse link
G Wdr35 WD repeat domain 35 multiple interactions EXP Edaravone inhibits the reaction [domoic acid results in increased expression of WDR35 protein] CTD PMID:23289926 NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19823
    role 19773
      chemical role 19341
        antioxidant 14445
          edaravone 74
Path 2
Term Annotations click to browse term
  CHEBI ontology 19823
    subatomic particle 19821
      composite particle 19821
        hadron 19821
          baryon 19821
            nucleon 19821
              atomic nucleus 19821
                atom 19821
                  main group element atom 19720
                    p-block element atom 19720
                      carbon group element atom 19643
                        carbon atom 19633
                          organic molecular entity 19633
                            organic molecule 19572
                              organic cyclic compound 19366
                                organic heterocyclic compound 18604
                                  heteroarene 16534
                                    monocyclic heteroarene 13441
                                      azole 12634
                                        diazole 8398
                                          pyrazoles 1906
                                            pyrazolone 78
                                              edaravone 74
paths to the root